Cadence Pharmaceuticals
Acquired
- Headquarters
- San Diego, California
- Employees
- 51–200
- Business Model
- B2B
- Website
- cadencepharm.com
- Total Funding
- $86.6M
- Last Round
- $86.6M Series AFeb 2009
About
Cadence Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on developing and commercializing products for use in the hospital setting, primarily targeting acute pain management. The company's lead product was Ofirmev (IV acetaminophen). Cadence raised approximately $197 million in funding before being acquired by Mallinckrodt PLC in 2014 for approximately $1.3 billion.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account